gabapentin has been researched along with Atrophy in 6 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this work was to investigate the efficacy of the GABAergic drug gabapentin in the treatment of the cerebellar signs caused by cortical cerebellar atrophy (CCA)." | 9.11 | Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study. ( Benavente, I; Errea, JM; Gazulla, J; Tordesillas, CJ, 2004) |
| "No causal treatment of ataxias is available at the moment, and so symptomatic and disease-modifying therapies are regarded as a reliable possibility for this complex group of movement disorders." | 5.35 | Gabapentin treatment improves motor coordination in a mice model of progressive ataxia. ( Calzà, L; D'Intino, G; Ferraro, L; Giardino, L; Gusciglio, M; Massella, A; Sivilia, S, 2009) |
| "Acute seizure activity was behaviorally scored and hemispheric brain atrophy measured." | 5.35 | Gabapentin neuroprotection and seizure suppression in immature mouse brain ischemia. ( Comi, AM; Johnston, MV; Kadam, SD; Mulholland, JD; Traa, BS, 2008) |
| "The aim of this work was to investigate the efficacy of the GABAergic drug gabapentin in the treatment of the cerebellar signs caused by cortical cerebellar atrophy (CCA)." | 5.11 | Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study. ( Benavente, I; Errea, JM; Gazulla, J; Tordesillas, CJ, 2004) |
| " Therefore, in women with a uterus, it is recommended that physicians prescribe combination therapy only to treat menopausal symptoms such as vasomotor symptoms (hot flashes) and vaginal atrophy, using the smallest effective dosage for the shortest possible duration." | 2.53 | Hormone Therapy and Other Treatments for Symptoms of Menopause. ( Crider, M; Hill, DA; Hill, SR, 2016) |
| "No causal treatment of ataxias is available at the moment, and so symptomatic and disease-modifying therapies are regarded as a reliable possibility for this complex group of movement disorders." | 1.35 | Gabapentin treatment improves motor coordination in a mice model of progressive ataxia. ( Calzà, L; D'Intino, G; Ferraro, L; Giardino, L; Gusciglio, M; Massella, A; Sivilia, S, 2009) |
| "Acute seizure activity was behaviorally scored and hemispheric brain atrophy measured." | 1.35 | Gabapentin neuroprotection and seizure suppression in immature mouse brain ischemia. ( Comi, AM; Johnston, MV; Kadam, SD; Mulholland, JD; Traa, BS, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nascimento-Alves, P | 1 |
| Fernandes-Silva, H | 1 |
| Aragão-Homem, C | 1 |
| Geraldes, R | 1 |
| Fonseca, AC | 1 |
| Hill, DA | 1 |
| Crider, M | 1 |
| Hill, SR | 1 |
| Massella, A | 1 |
| Gusciglio, M | 1 |
| D'Intino, G | 1 |
| Sivilia, S | 1 |
| Ferraro, L | 1 |
| Calzà, L | 1 |
| Giardino, L | 1 |
| Gazulla, J | 1 |
| Errea, JM | 1 |
| Benavente, I | 1 |
| Tordesillas, CJ | 1 |
| Horvath, J | 1 |
| Coeytaux, A | 1 |
| Jallon, P | 1 |
| Landis, T | 1 |
| Temperli, P | 1 |
| Burkhard, PR | 1 |
| Traa, BS | 1 |
| Mulholland, JD | 1 |
| Kadam, SD | 1 |
| Johnston, MV | 1 |
| Comi, AM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparative Effects of Clinical Pilates Training and Aerobic Exercise on Menopausal Symptoms, Quality of Life, Sleep and Depression[NCT05764031] | 30 participants (Actual) | Interventional | 2020-12-16 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for gabapentin and Atrophy
| Article | Year |
|---|---|
Hormone Therapy and Other Treatments for Symptoms of Menopause.
Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexa | 2016 |
1 trial available for gabapentin and Atrophy
| Article | Year |
|---|---|
Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study.
Topics: Acetates; Aged; Amines; Antiparkinson Agents; Atrophy; Cerebellar Ataxia; Cerebellar Cortex; Cyclohe | 2004 |
4 other studies available for gabapentin and Atrophy
| Article | Year |
|---|---|
IV and V cranial nerves dysfunction as initial manifestations of superficial siderosis of the central nervous system.
Topics: Aged; Amines; Angiography, Digital Subtraction; Atrophy; Central Nervous System Diseases; Cerebellum | 2016 |
Gabapentin treatment improves motor coordination in a mice model of progressive ataxia.
Topics: Age Factors; Amines; Analysis of Variance; Animals; Ataxia; Atrophy; Cell Count; Cerebellum; Chromat | 2009 |
Carbamazepine encephalopathy masquerading as Creutzfeldt-Jakob disease.
Topics: Aged; Amines; Analgesics, Non-Narcotic; Atrophy; Basal Ganglia; Brain; Brain Damage, Chronic; Carbam | 2005 |
Gabapentin neuroprotection and seizure suppression in immature mouse brain ischemia.
Topics: Amines; Animals; Animals, Newborn; Anticonvulsants; Atrophy; Behavior, Animal; Body Temperature; Bra | 2008 |